Published in Genetics on June 18, 2005
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity. Nat Commun (2013) 2.22
Evolutionary origins of invasive populations. Evol Appl (2008) 1.73
Antibiotic-resistant soil bacteria in transgenic plant fields. Proc Natl Acad Sci U S A (2008) 1.28
The balance between mutators and nonmutators in asexual populations. Genetics (2011) 1.02
Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. Evol Appl (2012) 0.97
Parasitic plants have increased rates of molecular evolution across all three genomes. BMC Evol Biol (2013) 0.96
Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat Commun (2014) 0.95
Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections. Infect Immun (2011) 0.92
Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother (2006) 0.92
Competition between transposable elements and mutator genes in bacteria. Mol Biol Evol (2012) 0.85
Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance. Antibiotics (Basel) (2013) 0.78
Prevalence of hypermutators among clinical Acinetobacter baumannii isolates. J Antimicrob Chemother (2015) 0.76
Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites. PLoS One (2016) 0.76
Systematically Altering Bacterial SOS Activity under Stress Reveals Therapeutic Strategies for Potentiating Antibiotics. mSphere (2016) 0.76
Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability. Genetics (2010) 0.75
High mutation frequencies among Escherichia coli and Salmonella pathogens. Science (1996) 10.88
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14
Role of mutator alleles in adaptive evolution. Nature (1997) 5.95
The population genetics of ecological specialization in evolving Escherichia coli populations. Nature (2000) 5.80
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science (1996) 5.08
Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science (2001) 3.76
Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science (1997) 3.67
Proliferation of mutators in A cell population. J Bacteriol (1997) 3.55
Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria. Genetics (1999) 2.60
The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness. Genetics (2000) 2.47
High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol (2002) 1.85
High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis (2003) 1.84
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis (2005) 1.81
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A (2002) 1.77
Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis (2003) 1.58
Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrob Agents Chemother (2002) 1.42
Lethal mutagenesis of HIV. Virus Res (2005) 1.26
Mismatch repair and response to DNA-damaging antitumour therapies. Eur J Cancer (2003) 1.26
Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol (2004) 1.25
Immune surveillance in colorectal carcinoma. Nat Genet (1995) 1.07
Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology (2004) 1.03
Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob Agents Chemother (2003) 1.01
Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet (2009) 8.51
A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat Protoc (2009) 4.84
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81
Randomized intubation with polyurethane or conical cuffs to prevent pneumonia in ventilated patients. Am J Respir Crit Care Med (2015) 4.74
Stress-induced mutagenesis in bacteria. Science (2003) 4.44
The population genetics of commensal Escherichia coli. Nat Rev Microbiol (2010) 3.78
System-wide changes to SUMO modifications in response to heat shock. Sci Signal (2009) 3.50
Selection versus demography: a multilocus investigation of the domestication process in maize. Mol Biol Evol (2004) 3.22
Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol (2010) 3.00
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother (2009) 2.85
The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother (2008) 2.66
UvrD helicase, unlike Rep helicase, dismantles RecA nucleoprotein filaments in Escherichia coli. EMBO J (2004) 2.59
Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics (2008) 2.51
Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol (2007) 2.44
Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol (2004) 2.29
Evolution of mutation rates in bacteria. Mol Microbiol (2006) 2.14
Reanalysis of phosphoproteomics data uncovers ADP-ribosylation sites. Nat Methods (2012) 2.12
Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit Care Med (2013) 2.05
Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother (2002) 2.04
Understanding the evolutionary fate of finite populations: the dynamics of mutational effects. PLoS Biol (2007) 1.95
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis (2006) 1.92
Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis (2005) 1.87
High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol (2002) 1.85
Regulation of translesion synthesis DNA polymerase eta by monoubiquitination. Mol Cell (2010) 1.84
The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics (2008) 1.81
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis (2005) 1.81
Purification and identification of endogenous polySUMO conjugates. EMBO Rep (2011) 1.72
Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol (2006) 1.68
Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol (2005) 1.67
Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis. PLoS One (2008) 1.62
Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J Antimicrob Chemother (2008) 1.59
Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates. Environ Microbiol (2006) 1.58
Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli. J Antimicrob Chemother (2006) 1.57
CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat Med (2007) 1.57
Mutation rate dynamics in a bacterial population reflect tension between adaptation and genetic load. Proc Natl Acad Sci U S A (2012) 1.56
Plasmids spread very fast in heterogeneous bacterial communities. Genetics (2002) 1.55
CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection. J Bacteriol (2011) 1.54
Evolution of mutational robustness in an RNA virus. PLoS Biol (2005) 1.54
Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal (2011) 1.54
Mutation Rate Inferred From Synonymous Substitutions in a Long-Term Evolution Experiment With Escherichia coli. G3 (Bethesda) (2011) 1.53
Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J Virol (2007) 1.50
A unique virus release mechanism in the Archaea. Proc Natl Acad Sci U S A (2009) 1.47
Molecular characterization of addiction systems of plasmids encoding extended-spectrum beta-lactamases in Escherichia coli. J Antimicrob Chemother (2010) 1.45
Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrob Agents Chemother (2002) 1.42
Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect Immun (2002) 1.41
Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J (2013) 1.40
Over-representation of repeats in stress response genes: a strategy to increase versatility under stressful conditions? Nucleic Acids Res (2002) 1.36
Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species. PLoS Pathog (2009) 1.35
Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors. J Clin Microbiol (2003) 1.34
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob Agents Chemother (2002) 1.32
Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization. J Bacteriol (2010) 1.32
Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli. Mol Microbiol (2007) 1.29
Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun (2009) 1.29
Capturing the mutational landscape of the beta-lactamase TEM-1. Proc Natl Acad Sci U S A (2013) 1.28
NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol (2010) 1.25
Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect Genet Evol (2011) 1.23
Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A (2013) 1.23
Involvement of Escherichia coli DNA polymerase IV in tolerance of cytotoxic alkylating DNA lesions in vivo. Genetics (2007) 1.20
Evidence for a human-specific Escherichia coli clone. Environ Microbiol (2008) 1.19
The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates. Infect Immun (2003) 1.18
Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections. PLoS Pathog (2010) 1.18
Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis (2010) 1.16
Evolutionary significance of stress-induced mutagenesis in bacteria. Trends Microbiol (2004) 1.15
Large chromosomal rearrangements during a long-term evolution experiment with Escherichia coli. MBio (2014) 1.14
Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect (2006) 1.14
The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions. Cell Cycle (2012) 1.13
The evolution of epistasis and its links with genetic robustness, complexity and drift in a phenotypic model of adaptation. Genetics (2009) 1.12
Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol (2010) 1.11
Epistasis and allele specificity in the emergence of a stable polymorphism in Escherichia coli. Science (2014) 1.10
Tempo and mode of genome evolution in a 50,000-generation experiment. Nature (2016) 1.10
Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress. BMC Evol Biol (2013) 1.09
Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients. J Med Virol (2005) 1.08
Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ Microbiol (2009) 1.08
Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol (2006) 1.07
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother (2014) 1.06
Early onset pneumonia: risk factors and consequences in head trauma patients. Anesthesiology (2004) 1.05
Impact of Drug Resistance on Virulence and Fitness of Bacterial Pathogens. Crit Care Med (2016) 1.05
Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother (2005) 1.04
Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.04
Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients. J Clin Microbiol (2003) 1.04
Selection acts on DNA secondary structures to decrease transcriptional mutagenesis. PLoS Genet (2006) 1.04
The amino acid valine is secreted in continuous-flow bacterial biofilms. J Bacteriol (2007) 1.03
Causes and consequences of DNA repair activity modulation during stationary phase in Escherichia coli. Crit Rev Biochem Mol Biol (2007) 1.02
Mutation rate and genome reduction in endosymbiotic and free-living bacteria. Genetica (2007) 1.02
Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J Antimicrob Chemother (2010) 1.00
Commensal Escherichia coli strains in Guiana reveal a high genetic diversity with host-dependant population structure. Environ Microbiol Rep (2012) 1.00